Consumer Goods » Clothing | Rafarma Pharmaceuticals Inc.

Rafarma Pharmaceuticals Inc. | Income Statement

Fiscal year is December-November. All values USD Thousands.
2013
2014
2018
2019
SG&A Expense
-
1.00
26.20
9.20
EBIT
-
1.00
97.10
5.60
Interest Expense
-
13.80
-
0.60
Pretax Income
-
14.80
97.10
6.20
Consolidated Net Income
-
14.80
97.10
6.20
Net Income
-
14.80
97.10
6.20
Net Income After Extraordinaries
0.00
14.80
97.10
6.20
Net Income Available to Common
-
14.80
97.10
6.20
EPS (Basic)
-
0.00
-
-
Basic Shares Outstanding
77,670.90
82,867.00
83,867
83,867
EPS (Diluted)
-
0.00
-
-
Diluted Shares Outstanding
77,670.90
82,867.00
83,867
83,867
EBITDA
-
1.00
97.10
-

About Rafarma Pharmaceuticals

View Profile
Address
203 South Main Street
Sheridan Wyoming 82801
United States
Employees -
Website http://www.rafarma.com
Updated 07/08/2019
Rafarma Pharmaceuticals, Inc. engages in the manufacture and marketing of pharmaceutical goods. It produces all types medical drugs in all delivery methods for various pharmacological groups. The company was founded on May 26, 2004 and is headquartered in Sheridan, WY.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.